Description

Erythrocyte membrane fatty acid profiles from supplementation trials demonstrate differential incorporation rates and plateau kinetics for EPA versus DHA.

Figure 39

Chart

Source Paper

Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?

Nutrients (2020)

PMID: 33276463

DOI: 10.3390/nu12123718

Cite This Figure

![Figure 39: Erythrocyte membrane fatty acid profiles from supplementation trials demonstrate differential incorporation rates and plateau kinetics for EPA versus DHA.]()

> Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." *Nutrients*, 2020. PMID: [33276463](https://pubmed.ncbi.nlm.nih.gov/33276463/)

<figure>
  <img src="" alt="Erythrocyte membrane fatty acid profiles from supplementation trials demonstrate differential incorporation rates and plateau kinetics for EPA versus DHA." />
  <figcaption>Figure 39. Erythrocyte membrane fatty acid profiles from supplementation trials demonstrate differential incorporation rates and plateau kinetics for EPA versus DHA.<br>  Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33276463/">33276463</a></figcaption>
</figure>

Preuves associées

Omega-3 Fatty Acids (EPA/DHA) pour Chronic Inflammation

Note A · 30 études